These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Human drug abuse liability: testing times ahead. Camà J Br J Addict; 1991 Dec; 86(12):1525-6. PubMed ID: 1786479 [No Abstract] [Full Text] [Related]
24. Monitoring drug markets in the Internet age and the evolution of drug monitoring systems in Australia. Burns L; Roxburgh A; Bruno R; Van Buskirk J Drug Test Anal; 2014; 6(7-8):840-5. PubMed ID: 24574080 [TBL] [Abstract][Full Text] [Related]
25. Drug abuse in America: medical and socio-legal dilemmas. Garcia SA Med Law; 1992; 11(5-6):323-35. PubMed ID: 1484457 [TBL] [Abstract][Full Text] [Related]
26. The social epidemiology of international drug trafficking: comparison of source of supply and distribution networks. Montagne M Int J Addict; 1990 May; 25(5):557-77. PubMed ID: 2258261 [TBL] [Abstract][Full Text] [Related]
27. Response to commentaries. Wilkins C Addiction; 2014 Oct; 109(10):1593-4. PubMed ID: 25163708 [No Abstract] [Full Text] [Related]
28. Assessing the 'added value' of European policy on new psychoactive substances. Chatwin C Int J Drug Policy; 2017 Feb; 40():111-116. PubMed ID: 27956185 [TBL] [Abstract][Full Text] [Related]
29. Cracking down on ecstasy. Law enforcement is treating the 'hug drug' as if it were the next cocaine. Is it? Ragavan C US News World Rep; 2001 Feb; 130(5):14-7. PubMed ID: 11211524 [No Abstract] [Full Text] [Related]
30. Against excess. Krajewski K Addiction; 2012 Nov; 107(11):1900-1. PubMed ID: 23039747 [No Abstract] [Full Text] [Related]
31. Should drugs be legalized? Implications of the debate for the mental health field. Frances RJ Hosp Community Psychiatry; 1991 Feb; 42(2):119-20, 125. PubMed ID: 1741801 [No Abstract] [Full Text] [Related]
32. The dangerous charms of the unknown. Reuter P Addiction; 2012 Nov; 107(11):1902-3. PubMed ID: 23039749 [No Abstract] [Full Text] [Related]
33. Prevalence of new psychoactive substances in Northeast Asia from 2007 to 2015. Lee J; Yang S; Kang Y; Han E; Feng LY; Li JH; Chung H Forensic Sci Int; 2017 Mar; 272():1-9. PubMed ID: 28088088 [TBL] [Abstract][Full Text] [Related]
34. Supply reduction's hidden casualties: a view from the trenches. Strathdee SA; Patterson TL Addiction; 2009 Mar; 104(3):340-1; discussion 345-6. PubMed ID: 19207337 [No Abstract] [Full Text] [Related]
35. Public policy statement on persons with alcohol and other drug (AOD) problems and the criminal justice system. American Society of Addiction Medicine. J Addict Dis; 1994; 13(4):234-7. PubMed ID: 7734472 [No Abstract] [Full Text] [Related]
36. Ethical and legal issues in the control of drug abuse and drug trafficking: the Nigerian case. Obot IS Soc Sci Med; 1992 Aug; 35(4):481-93. PubMed ID: 1519101 [TBL] [Abstract][Full Text] [Related]
37. Why the U.S. Government is not contributing to the resolution of the nation's drug problem. Chambliss WJ Int J Health Serv; 1994; 24(4):675-90. PubMed ID: 7896469 [TBL] [Abstract][Full Text] [Related]
38. Responding to New Psychoactive Substances in the European Union: Early Warning, Risk Assessment, and Control Measures. Evans-Brown M; Sedefov R Handb Exp Pharmacol; 2018; 252():3-49. PubMed ID: 30194542 [TBL] [Abstract][Full Text] [Related]
39. 'Legal highs' an inappropriate term for 'Novel Psychoactive Drugs' in drug prevention and scientific debate. Corazza O; Demetrovics Z; van den Brink W; Schifano F Int J Drug Policy; 2013 Jan; 24(1):82-3. PubMed ID: 22883544 [No Abstract] [Full Text] [Related]
40. New Zealand to establish fit for purpose regulation for new psychoactive substances. Sheridan J; Atmore B; Russell B Addiction; 2012 Nov; 107(11):1901-2. PubMed ID: 23039748 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]